Articles about Product Safety

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Exelixis Stock Slips as FDA Delays Cancer Drug Review, Analyst Weighs In ↗

Today 14:02 EDT

Via Benzinga

FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)

Today 13:36 EDT

Via PRLog

Kaplan Fox Encourages Investors of Medline Inc. (NASDAQ: MDLN) to Contact the Firm Regarding an Investigation Into Possible Securities Law Violations

Today 11:35 EDT

Via NewMediaWire

Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before the Lead Plaintiff Deadline on November 3, 2026

Today 11:00 EDT

Via NewMediaWire

Kaplan Fox Notifies Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Investors of an Investigation Into Possible Securities Law Violations

Today 10:40 EDT

Via NewMediaWire

Exelixis, An IBD 50 Stock, Pulls A Bearish Move With Surprise Cancer Delay ↗

Today 10:10 EDT

Via Investor's Business Daily

Inovio Nears FDA Decision on INO-3107 as Oct. 30 PDUFA Date Looms ↗

Today 9:02 EDT

Via MarketBeat

Set Yourself Up for a Strong 2027: 2 Pharmaceutical Stocks to Buy in September ↗

Today 5:35 EDT

Via The Motley Fool

Creative Biolabs Expands IND-Enabling Live Biotherapeutic Product Safety Assessment Capabilities

Today 3:56 EDT

Via Get News

Why Researchers Trust Premier Aminos for High-Quality Peptides

Today 2:50 EDT

Via BusinesNews Wire

Before the First Stroke: Why the Consultation Is Where Permanent Makeup Results Are Actually Made

Today 0:50 EDT

Via Get News

Katie Nielsen Reflects on Why Every Courtroom Experience Should Make an Attorney Better

September 10, 2026

Via Get News

Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) is September 28, 2026

September 10, 2026

Via NewMediaWire

The Peptide Research Sector Is Quietly Becoming One of Canada’s Fastest-Growing Biotech Segments

September 10, 2026

Via AB Newswire

Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Contact the Firm Before Lead Plaintiff Deadline on November 3, 2026

September 10, 2026

Via NewMediaWire

Institutional Investors Are Loading Up on Madrigal Pharmaceuticals Stock. Should You? ↗

September 10, 2026

Via The Motley Fool

SS Innovations International Inc. (NASDAQ: SSII) Brings Robotic Cardiac Surgery to Sri Lanka

September 10, 2026

Via Investor Brand Network

Kaplan Fox Encourages Investors of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) to Contact the Firm to Learn About Their Legal Rights

September 10, 2026

Via NewMediaWire

FDA Pauses New Enrollment for Biohaven Epilepsy Drug Program ↗

September 10, 2026

Via Benzinga

MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance

September 10, 2026

Via Investor Brand Network

Kaplan Fox Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026

September 10, 2026

Via NewMediaWire

MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance

September 10, 2026

Via Investor Brand Network

Kaplan Fox Reminds Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to a Securities Class Action Deadline - Contact the Firm Before November 3, 2026

September 10, 2026

Via NewMediaWire

Inovio Pharmaceuticals Nears Oct. 30 FDA Decision for INO-3107 in RRP ↗

September 10, 2026

Via MarketBeat

3 Quality Compounders with Impressive Fundamentals

September 10, 2026

Via StockStory

Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Contact the Firm to Learn About Their Legal Rights

September 09, 2026

Via NewMediaWire

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Seeking Recovery to Contact the Firm Before September 28, 2026

September 09, 2026

Via NewMediaWire

FDA Issues Complete Response Letter for AbbVie’s Fast-Acting Neurotoxin TrenibotE; Spokane dermatologist Dr. Philip Werschler on What the Letter Means ↗

September 09, 2026

Via Talk Markets

What Running Dozens of Simultaneous Clinical Trials Revealed About How Medicine Actually Gets Made: Dr. Phil Werschler on the Research Behind the Results ↗

September 09, 2026

Via Talk Markets

Nova Warranty Addresses Coverage Gaps for Mercedes-Benz Owners Following Largest Recall Year

September 09, 2026

Via Press Advantage

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.